Answer
Besponsa contains less than 1 mmol sodium (23 mg) per 1 mg of inotuzumab ozogamicin and is essentially sodium-free, although sodium-containing preparation solutions must be considered in the total sodium administered.
Sources for this answer
- BESPONSA 1 mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 11Document updated
Sources checked